CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12,760 enrolled
Drug / intervention
VAX-MOM Intervention +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04444518
NCT04444518N/ACompleted

The VAX-MOM Study: Increasing Influenza and Tdap Vaccination of Pregnant Women

University of Rochester·interventional·Posted Jun 23, 2020·Updated Jan 10, 2025

In Brief

A clinical study evaluating VAX-MOM Intervention and Standard of Care for Immunization; Infection and Pregnancy Related. Completed, enrolled 12,760 participants across 1 site.

Detailed Summary

Pregnant women who get influenza are more likely than non-pregnant women to have serious complications, including hospitalizations, death, preterm labor and premature birth. Pertussis can cause hospitalization or death for newborns. However, influenza and Tdap vaccination rates for pregnant women are low nationally. In this study, the investigators will perform a randomized controlled trial aimed at practice change in obstetricians' offices, with an overall goal of reducing morbidity and mortality from influenza and pertussis infections.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 23, 2020
Enrollment StartJul 1, 2019
Primary CompletionJun 30, 2022
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 6.0 years ago

Interventions

VAX-MOM Interventionbehavioral

The multi-component VAX-MOM intervention will be comprised of: training in communication, provider prompts, standing orders, and feedback on vaccination rates.

Standard of Carebehavioral

Standard vaccine education and processes provided to patients by obstetric practices.